| scholarly article | Q13442814 |
| P2093 | author name string | Nehal N Mehta | |
| Peter C Grayson | |||
| Mark A Ahlman | |||
| Casey A Rimland | |||
| Joel S Rosenblum | |||
| Kaitlin A Quinn | |||
| P2860 | cites work | Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis | Q26852724 |
| Medium- and large-vessel vasculitis | Q28196695 | ||
| Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. | Q33624365 | ||
| The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis | Q34227003 | ||
| Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 | ||
| Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization | Q36256143 | ||
| Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis | Q37060375 | ||
| Clinical features of polymyalgia rheumatica and giant cell arteritis | Q38028863 | ||
| Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification | Q38397910 | ||
| The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis | Q38547761 | ||
| Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis | Q38605303 | ||
| Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT | Q38628616 | ||
| Takayasu arteritis | Q43829353 | ||
| Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio | Q43936771 | ||
| Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis. | Q46710038 | ||
| Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials. | Q47158087 | ||
| Positron Emission Tomography as an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis. | Q47836073 | ||
| Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. | Q52578815 | ||
| Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. | Q53073312 | ||
| Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study. | Q53096424 | ||
| Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation. | Q53104200 | ||
| Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction. | Q53510699 | ||
| FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. | Q54238129 | ||
| Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study | Q59130566 | ||
| 18F-FDG PET as a diagnostic procedure in large vessel vasculitis—a controlled, blinded re-examination of routine PET scans | Q82037506 | ||
| F-18 FDG PET for assessment of disease activity of large vessel vasculitis: A systematic review and meta-analysis | Q91015960 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 15180 | |
| P577 | publication date | 2019-10-23 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis | |
| P478 | volume | 9 |
Search more.